Combination of a steroid sulfatase inhibitor and an ascomycin

Details for Australian Patent Application No. 2006224797 (hide)

Owner Novartis AG

Inventors Meingassner, Josef Gottfried

Agent Davies Collison Cave

Pub. Number AU-B-2006224797

PCT Pub. Number WO2006/097293

Priority 0505539.7 17.03.05 GB

Filing date 15 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 18 December 2008

International Classifications

A61K 31/436 (2006.01)

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/097293 Priority application(s): WO2006/097293

18 December 2008 Application Accepted

  Published as AU-B-2006224797

23 April 2009 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224810-Device for mixing mixable and unmixable liquids and/or for creating emulsions, and container with a dosing nozzle, and container with a diagonal (connecting) tube

2006224796-Anti-inflammatory compounds